Board meeting on November 2 to approve unaudited results for quarter and half year ended September 30, 2026
Board meeting set for Monday, November 02, 2026.
By ScoutQuest · · 1 min read
- Board Meeting Date
- Monday, November 02, 2026
- Results Period
- quarter and half year ended September 30, 2026
- Trading Window Closure
- closed from October 01, 2026; reopens 48 hours after results are declared and submitted to the exchanges
What the update says
The company has informed the National Stock Exchange and BSE that a meeting of its Board of Directors is scheduled for Monday, November 02, 2026. The stated purpose is to consider and approve the Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2026.
Trading window
- The trading window for dealing in the company's shares is already closed for all Directors, KMPs, Designated Employees and Connected Persons from October 01, 2026.
- It will remain closed until the end of 48 hours after the said financial results are declared and submitted to the stock exchanges.
- The closure follows the company's Code of Conduct under the SEBI (Prohibition of Insider Trading) Regulations, 2015, and was flagged earlier through the company's letter dated September 25, 2026.
How to read this
This is a date intimation for the results announcement. Investors typically watch such notices for the day the numbers will be made public, since the standalone and consolidated results for both the quarter and the half year will be considered together at that meeting.
What is not part of this notice
The update does not carry any financial figures, dividend proposal or other business item for the meeting; it sets out the results agenda and the trading window timeline only.
Also from Sun Pharma Advanced Research Company
Analyst Kunal expects double-digit constant currency growth in Sun Pharma's specialty business this quarter, with updates awaited on the organon acquisition closing expected in Q1 calendar 2027
16 Oct 2026
CESTAT upholds order in company's favour, confirms entitlement to refund of CENVAT credit of Rs. 2751 Lakhs
4 Oct 2026
Sun Pharma signed a global exclusive licensing deal with LIB Therapeutics to commercialize a cholesterol-lowering drug outside the US and China, sparking bullish brokerage views
29 Sep 2026
More numbers
- Trading window remains closed until 48 hours after results are declared48 hours
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.